This story was first published in digitalhealth.net

A £26 million pharmaceutical manufacturing unit, Torbay Pharmaceuticals, has opened in Paignton.
The unit, part of Torbay and South Devon NHS Foundation Trust, is 78,000 square feet and is fully equipped with the latest technology. It is located on Wilkins Drive.
The unit allows research and development of new medicine products, which are then sold to and used by UK NHS hospitals and healthcare organisations globally. It is the largest NHS manufacturer of sterile products in England.
Proceeds of the income will be circulated back into local health care in Torbay and South Devon. This provides an annual multi-million pound cash injection for the local population’s health care needs.
Before the unit was built, Torbay Pharmaceuticals’ units were spread across four different sites across Torbay. Work began to prepare the new site in March 2013.
Richard Ibbotson, chairman of Torbay and South Devon NHS Foundation Trust, said: "We are incredibly proud of Torbay Pharmaceuticals and all that they have achieved over the years. Not only have they created a range of highly skilled career opportunities, but they generate income which directly supports the health and care of local people. This is a first-rate example of what innovation in the NHS can contribute to local communities.
"These fabulous new facilities offer a modern, class-leading environment which will enable Torbay Pharmaceuticals to further grow and flourish. I, on behalf of the Trust Board, cannot thank everyone enough for their hard work in seeing this superb project come to fruition."
Emma Rooth, managing director of Torbay Pharmaceuticals, said: "Torbay Pharmaceuticals is proud to be such a successful part of Torbay and South Devon NHS Foundation Trust. Being part of the NHS enables us to have our finger on the pulse of health care needs and respond appropriately with new products, plugging shortages and anticipating the latest developments in medical science.
"Since the establishment of the original pharmaceutical department at Torbay Hospital back in the 1970s, we have grown from strength to strength to meet not only our local population's needs, but also the needs of the wider NHS and health care providers globally.
"The official opening of our new class-leading sterile product facility is a very exciting time for Torbay Pharmaceuticals. By strengthening our production capabilities and ensuring the delivery of high quality products for our patients through this investment, we have created the platform upon which we can achieve significant growth for the organisation, its people and the region."
This story was first published in digitalhealth.net
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly